The Rebound Reality
Clinical data surrounding GLP-1 cessation is stark: the landmark STEP 1 extension trial showed that patients regained two-thirds of their lost weight within one year of stopping semaglutide. GLP-1s lower entirely your body's biological "set point," but they do not permanently rewrite it.
When the medication is removed, gastric emptying accelerates, baseline appetite returns (often with a vengeance), and basal metabolic rate recalibrates, making massive rebound weight gain almost physically inevitable without a rigorous maintenance protocol.
Phase 1: The Taper Protocol
The most critical mistake is "cold turkey" cessation. Instead, clinicians utilize a micro-dosing taper schedule, spreading out the half-life degradation over months. If the maintenance dose was 2.4mg weekly, a taper might involve dropping to 1.7mg for 4 weeks, 1.0mg for 4 weeks, 0.5mg every 10 days, and eventually 0.25mg every 14 days.
This agonizingly slow reduction allows the endogenous incretin system to gradually "wake up" and the hypothalamus to slowly adapt to decreasing exogenous GLP-1 saturation without triggering panic starvation signals.
Phase 2: Muscle Preservation and Resistance Training
GLP-1 weight loss is not completely targeted fat loss; up to 30-40% of the weight shed can be lean muscle mass. Muscle is metabolically active tissue. Losing it destroys your basal metabolic rate (BMR).
During the tapering phase, a hyper-aggressive resistance training program combined with protein overfeeding (1.0g-1.2g per lb of body weight) is mandatory to rebuild BMR. You cannot maintain the new lower weight if your new muscle-depleted metabolism only burns 1400 calories a day.

Phase 3: Maintenance Peptide Bridges
In specialized biohacking circles, users are bridging the gap utilizing milder compounds to manage glucose and inflammation post-GLP-1. Peptides like MOTS-c (for mitochondrial function and insulin sensitivity) and AOD-9604 (for targeted lipolysis) are frequently discussed as maintenance tools to prevent rebound.
Ultimately, metabolic adaptation requires permanent lifestyle changes. GLP-1s are a tool to build the bridge, but metabolic conditioning must carry you across.